These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 6697270)

  • 1. Pulmonary complications in patients receiving granulocyte transfusions and amphotericin B.
    Bow EJ; Schroeder ML; Louie TJ
    Can Med Assoc J; 1984 Mar; 130(5):593-7. PubMed ID: 6697270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary complications during granulocyte transfusions: incidence and clinical features.
    Karp DD; Ervin TJ; Tuttle S; Gorgone BC; Lavin P; Yunis EJ
    Vox Sang; 1982 Feb; 42(2):57-61. PubMed ID: 7064430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled study of therapeutic granulocyte transfusions in granulocytopenic patients with severe infections.
    Matsue K; Harada M; Nakao S; Ueda M; Kondo K; Odaka K; Mori T; Hattori K
    Jpn J Clin Oncol; 1984 Mar; 14(1):21-30. PubMed ID: 6368906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of therapeutic early onset granulocyte transfusions in pediatric patients with neutropenia and severe infections.
    Sachs UJ; Reiter A; Walter T; Bein G; Woessmann W
    Transfusion; 2006 Nov; 46(11):1909-14. PubMed ID: 17076845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized clinical trial of granulocyte transfusions for infection in acute leukemia.
    Alavi JB; Root RK; Djerassi I; Evans AE; Gluckman SJ; MacGregor RR; Guerry D; Schreiber AD; Shaw JM; Koch P; Cooper RA
    N Engl J Med; 1977 Mar; 296(13):706-11. PubMed ID: 320477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A controlled trial of prophylactic granulocyte transfusions during initial induction chemotherapy for acute myelogenous leukemia.
    Strauss RG; Connett JE; Gale RP; Bloomfield CD; Herzig GP; McCullough J; Maguire LC; Winston DJ; Ho W; Stump DC; Miller WV; Koepke JA
    N Engl J Med; 1981 Sep; 305(11):597-603. PubMed ID: 6790985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulocyte transfusion therapy and amphotericin B: adverse reactions?
    Dutcher JP; Kendall J; Norris D; Schiffer C; Aisner J; Wiernik PH
    Am J Hematol; 1989 Jun; 31(2):102-8. PubMed ID: 2735316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The treatment of infections in granulocytopenic patients with granulocyte transfusions.
    Mód A; Harsányi V; Jakschitz M; Hollán SR
    Haematologia (Budap); 1977; 11(1-2):31-40. PubMed ID: 352851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of quantity of granulocytes transfused on response.
    Winton EF; Moffitt S; Vogler WR; Mallard HE; Lawson DH; Malcom LG; Montagne ML
    Prog Clin Biol Res; 1982; 88():75-91. PubMed ID: 6954550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of granulocyte transfusions for neutropenia-related infections: retrospective analysis of predictive factors.
    Rutella S; Pierelli L; Sica S; Serafini R; Chiusolo P; Paladini U; Leone F; Zini G; D'Onofrio G; Leone G; Piccirillo N
    Cytotherapy; 2003; 5(1):19-30. PubMed ID: 12745586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amphotericin B vs high-dose ketoconazole for empirical antifungal therapy among febrile, granulocytopenic cancer patients. A prospective, randomized study.
    Walsh TJ; Rubin M; Hathorn J; Gress J; Thaler M; Skelton J; McKnight J; Browne M; Marshall D; Cotton D
    Arch Intern Med; 1991 Apr; 151(4):765-70. PubMed ID: 2012462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant interferon gamma1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions.
    Safdar A; Rodriguez GH; Lichtiger B; Dickey BF; Kontoyiannis DP; Freireich EJ; Shpall EJ; Raad II; Kantarjian HM; Champlin RE
    Cancer; 2006 Jun; 106(12):2664-71. PubMed ID: 16691620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of clinical practice policy on the continuous intravenous administration of amphotericin B deoxycholate.
    Maharom P; Thamlikitkul V
    J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S118-24. PubMed ID: 17718252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Indications and clinical aspects of granulocyte transfusions (author's transl)].
    Graubner M; Kretschmer V; Löffler H; Mueller-Eckhardt C; Pralle H
    Dtsch Med Wochenschr; 1981 Dec; 106(51-52):1726-32. PubMed ID: 7327089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive fungal sinusitis in patients undergoing bone marrow transplantation.
    Drakos PE; Nagler A; Or R; Naparstek E; Kapelushnik J; Engelhard D; Rahav G; Ne'emean D; Slavin S
    Bone Marrow Transplant; 1993 Sep; 12(3):203-8. PubMed ID: 8241977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of two types of granulocyte transfusions in patients with acute leukemia and septicemia.
    Morse EE; Synder E; Blumberg N; Katz AJ
    Ann Clin Lab Sci; 1982; 12(2):106-10. PubMed ID: 7073236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant administration of granulocyte transfusions and amphotericin B in neutropenic patients: absence of significant pulmonary toxicity.
    Dana BW; Durie BG; White RF; Huestis DW
    Blood; 1981 Jan; 57(1):90-4. PubMed ID: 7004533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulocyte transfusions for neutropenic patients with life-threatening infections: a single centre experience in 47 patients, who received 348 granulocyte transfusions.
    Ofran Y; Avivi I; Oliven A; Oren I; Zuckerman T; Bonstein L; Rowe JM; Dann EJ
    Vox Sang; 2007 Nov; 93(4):363-9. PubMed ID: 18070282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granulocyte enriched buffy coat transfusions in neutropenic patients.
    Reiss RF; Atamer MA; Waldman AA
    Haematologia (Budap); 1985; 18(4):265-71. PubMed ID: 3836161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of fluconazole prophylaxis to reduce mortality or the requirement of systemic amphotericin B therapy during treatment for refractory acute myeloid leukemia: results of a prospective randomized phase III study. German AML Cooperative Group.
    Kern W; Behre G; Rudolf T; Kerkhoff A; Grote-Metke A; Eimermacher H; Kubica U; Wörmann B; Büchner T; Hiddemann W
    Cancer; 1998 Jul; 83(2):291-301. PubMed ID: 9669812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.